Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / *W EXP 08/10/202
-
Total 13F shares
-
3,251,387
-
Share change
-
+26,171
-
Total reported value
-
$3,332,596
-
Price per share
-
$1.00
-
Number of holders
-
22
-
Value change
-
-$25,382
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) as of Q1 2024
As of 31 Mar 2024,
TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,251,387 shares.
The largest 10 holders included
Magnetar Financial LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Polar Asset Management Partners Inc., Exos Asset Management LLC, Vestcor Inc, MSD Partners, L.P., WOLVERINE ASSET MANAGEMENT LLC, Bracebridge Capital, LLC, and Walleye Capital LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.